Lucas Regis

566 total citations
62 papers, 382 citations indexed

About

Lucas Regis is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lucas Regis has authored 62 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 22 papers in Rheumatology and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lucas Regis's work include Prostate Cancer Treatment and Research (44 papers), Prostate Cancer Diagnosis and Treatment (42 papers) and Urologic and reproductive health conditions (17 papers). Lucas Regis is often cited by papers focused on Prostate Cancer Treatment and Research (44 papers), Prostate Cancer Diagnosis and Treatment (42 papers) and Urologic and reproductive health conditions (17 papers). Lucas Regis collaborates with scholars based in Spain, Palestinian Territory and United Kingdom. Lucas Regis's co-authors include Jacques Planas, Juan Moróte, A. Celma, Enrique Trilla, J. Placer, S. Roche, Richard Mast, Inés M. de Torres, Roser Ferrer and Anna Santamaría and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and BioMed Research International.

In The Last Decade

Lucas Regis

58 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucas Regis Spain 11 323 109 87 52 51 62 382
C. Sturgeon United Kingdom 3 166 0.5× 28 0.3× 73 0.8× 15 0.3× 48 0.9× 3 295
Shuai Hu China 10 123 0.4× 24 0.2× 32 0.4× 57 1.1× 77 1.5× 18 310
Sergio Serni Italy 10 152 0.5× 33 0.3× 28 0.3× 26 0.5× 45 0.9× 31 248
Priyanka Sehgal United States 10 118 0.4× 20 0.2× 47 0.5× 49 0.9× 25 0.5× 16 257
Laura Wiemer Germany 7 169 0.5× 76 0.7× 67 0.8× 20 0.4× 106 2.1× 22 325
K. Kadesky United States 6 236 0.7× 37 0.3× 19 0.2× 19 0.4× 110 2.2× 6 291
Dexin Dong China 8 92 0.3× 29 0.3× 50 0.6× 26 0.5× 66 1.3× 20 260
Mayuko Kanayama Japan 7 133 0.4× 29 0.3× 10 0.1× 20 0.4× 15 0.3× 16 202
Bostwick Dg United States 9 217 0.7× 94 0.9× 6 0.1× 17 0.3× 51 1.0× 10 266
Shams Halat United States 10 218 0.7× 65 0.6× 7 0.1× 28 0.5× 74 1.5× 23 301

Countries citing papers authored by Lucas Regis

Since Specialization
Citations

This map shows the geographic impact of Lucas Regis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas Regis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas Regis more than expected).

Fields of papers citing papers by Lucas Regis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas Regis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas Regis. The network helps show where Lucas Regis may publish in the future.

Co-authorship network of co-authors of Lucas Regis

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas Regis. A scholar is included among the top collaborators of Lucas Regis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas Regis. Lucas Regis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garín, Olatz, José Francisco Suárez, Cristina Gutiérrez, et al.. (2023). Comparative effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measures. Clinical and Translational Radiation Oncology. 44. 100694–100694. 2 indexed citations
2.
Regis, Lucas, A. Celma, Inés de Torres, et al.. (2023). Relationship between Proclarix and the Aggressiveness of Prostate Cancer. Molecular Diagnosis & Therapy. 27(4). 487–498. 2 indexed citations
3.
Celma, A., et al.. (2022). Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic Review. Cancers. 14(19). 4747–4747. 16 indexed citations
4.
Moróte, Juan, Lucas Regis, A. Celma, et al.. (2022). Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?. The International Journal of Biological Markers. 37(2). 218–223. 3 indexed citations
5.
Regis, Lucas, Mathias Winkler, Nicolás Valdés Ortega, et al.. (2022). Multiparametric MRI for Staging of Prostate Cancer: A Multicentric Analysis of Predictive Factors to Improve Identification of Extracapsular Extension before Radical Prostatectomy. Cancers. 14(16). 3966–3966. 7 indexed citations
6.
Moróte, Juan, Ángel Borque‐Fernando, A. Celma, et al.. (2022). Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy. Cancers. 14(10). 2374–2374. 3 indexed citations
7.
Moróte, Juan, Ángel Borque‐Fernando, A. Celma, et al.. (2022). Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer. Cancers. 14(7). 1828–1828. 8 indexed citations
9.
Moróte, Juan, Ángel Borque‐Fernando, A. Celma, et al.. (2022). The Barcelona Predictive Model of Clinically Significant Prostate Cancer. Cancers. 14(6). 1589–1589. 22 indexed citations
10.
Moróte, Juan, Lucas Regis, A. Celma, et al.. (2022). Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI. Cancers. 14(11). 2702–2702. 4 indexed citations
11.
Moróte, Juan, A. Celma, Lucas Regis, et al.. (2022). The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer. The World Journal of Men s Health. 40(2). 270–270. 9 indexed citations
12.
Planas, Jacques, A. Celma, Lucas Regis, et al.. (2022). Application of One-Step Nucleic Acid Amplification (OSNA) in different cancer entities and usefulness in prostate cancer: a systematic review. BMC Cancer. 22(1). 357–357. 4 indexed citations
13.
Celma, A., et al.. (2022). Systematic review of methods used to improve the efficacy of magnetic resonance in early detection of clinically significant prostate cancer. Actas Urológicas Españolas (English Edition). 47(3). 127–139. 2 indexed citations
14.
Regis, Lucas, Jacques Planas, A. Celma, et al.. (2021). A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy. European Urology Oncology. 5(4). 460–463. 7 indexed citations
15.
Moróte, Juan, A. Celma, S. Roche, et al.. (2021). The current recommendation for the management of isolated high‐grade prostatic intraepithelial neoplasia. British Journal of Urology. 129(5). 627–633. 7 indexed citations
16.
Moróte, Juan, A. Celma, José Fernando Jiménez Díaz, et al.. (2020). Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging result. Urologic Oncology Seminars and Original Investigations. 38(5). 410–417. 11 indexed citations
17.
Moróte, Juan, Ángel Borque‐Fernando, Luis Esteban, et al.. (2020). Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findings. Urologic Oncology Seminars and Original Investigations. 39(7). 432.e11–432.e19. 4 indexed citations
18.
Borque‐Fernando, Ángel, Luis Esteban, A. Celma, et al.. (2019). How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies. World Journal of Urology. 38(6). 1481–1491. 8 indexed citations
19.
Trilla, Enrique, Anna Meseguer, Jacques Planas, et al.. (2018). Valor de la proteína STAT3 como factor pronóstico en el carcinoma renal de célula clara. Revisión sistemática. Actas Urológicas Españolas. 43(3). 118–123. 9 indexed citations
20.
Trilla, Enrique, Anna Meseguer, Jacques Planas, et al.. (2016). Revisión sistemática de los factores pronósticos del carcinoma renal. Actas Urológicas Españolas. 41(4). 215–225. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026